- Home
- COKE vs RGC Comparison
COKE vs RGC Comparison
Compare COKE & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COKE | RGC |
|---|---|---|
| Founded | 1902 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.5B | 11.5B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | COKE | RGC |
|---|---|---|
| Price | $184.58 | $23.82 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 453.3K | 106.6K |
| Earning Date | 04-29-2026 | 10-31-2025 |
| Dividend Yield | ★ 0.55% | N/A |
| EPS Growth | ★ 156.81 | N/A |
| EPS | ★ 1.21 | N/A |
| Revenue | ★ $7,228,055,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $149.56 | ★ N/A |
| Revenue Growth | ★ 4.76 | N/A |
| 52 Week Low | $105.21 | $9.39 |
| 52 Week High | $1,433.97 | $950.00 |
Technical Indicators
Market Signals| Indicator | COKE | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 42.75 | 44.29 |
| Support Level | $110.61 | $21.20 |
| Resistance Level | $209.24 | $29.26 |
| Average True Range (ATR) | 7.37 | 2.47 |
| MACD | -4.84 | 0.12 |
| Stochastic Oscillator | 18.99 | 17.08 |
Price Performance
Historical ComparisonAbout COKE Coca-Cola Consolidated Inc.
Coca-Cola Consolidated Inc distributes, markets, and manufactures nonalcoholic beverages. It offers a range of nonalcoholic beverage products and flavors, including both sparkling and still beverages. Sparkling beverages are carbonated beverages, and the Company's principal sparkling beverage is Coca-Cola. Still beverages include energy products and non-carbonated beverages such as bottled water, ready-to-drink tea, ready-to-drink coffee, enhanced water, juices, and sports drinks. The Company has two operating segments: Nonalcoholic Beverages and All Other and . Key revenue is generated from Nonalcoholic Beverages.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.